The number of physicians approved by the state Department of Health (DOH) to certify patients to participate in Pennsylvania’s Medical Marijuana Program has been steadily growing since the registry opened in November 2017. As of February 2, 2018, DOH has approved hundreds of doctors across the Commonwealth to participate in the program. A complete list of certified physicians, last updated February 12, 2018, is available via DOH’s website.
In order to qualify, patients must have one or more of the 17 currently-approved qualifying medical conditions:
● Amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s Disease)
● Crohn’s disease
● Huntington’s disease
● Inflammatory bowel disease
● Intractable seizures
● Multiple sclerosis
● Parkinson’s disease
● Post-traumatic stress disorder (PTSD)
● Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain in which conventional therapeutic intervention and opiate therapy is contraindicated or ineffective
● Damage to the nervous tissue of the spinal cord (with objective neurological indication of intractable spasticity)
● Sickle cell anemia
Medical marijuana will be available in Pennsylvania via dispensaries in pills, oils, topical gels and creams, liquid, tincture, and forms appropriate for vaporization and nebulization.